z-logo
open-access-imgOpen Access
Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
Author(s) -
Liu Zaoqu,
Guo Chunguang,
Li Jing,
Xu Hui,
Lu Taoyuan,
Wang Libo,
Liu Long,
Han Xinwei
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
ISSN - 2001-1326
DOI - 10.1002/ctm2.619
Subject(s) - chek2 , medicine , cancer , palb2 , oncology , cancer research , head and neck squamous cell carcinoma , synthetic lethality , lung cancer , breast cancer , rad51 , homologous recombination , mutation , head and neck cancer , germline mutation , gene , dna repair , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom